Primer vezikoüreteral reflünün tedavisinde endoskopik subüreteral kollajen enjeksiyonunun uzun dönem etkinliği

Primer vezikoüreteral reflünün (VUR) tedavisinde subüreteral kollajen enjeksiyonunun uzun dönem etkinliğini retrospektif olarak değerlendirdik. Toplam 32 renal ünite subüreteral kollajen enjeksiyonu ile tedavi edildi. Grade 1, 4 ve 5 reflülü ve ciddi alt üriner sistem disfonksiyonlu hastalar çalışma dışı bırakıldı. Tek enjeksiyon sonrası 1. ayda halen reflüsü devam eden hastalar dışlandıktan sonra, 36 ay takibi tamamlayan 32 renal ünite çalışmaya dahil edilmiştir. 6. ayda 32 renal üniteden 21'inde (%65.6) reflü yoktu. Tek enjeksiyon ve bir kez tekrarlanan enjeksiyon sonrası sırasıyla, 12 ay takipte 18 (%56.2) ve 22 (%68.7) renal ünitede halen reflü yoktu; 24 ay takipte 14 (%43.7) ve 17 (%53.1) renal ünitede reflü görülmedi. 36 aylık takiplerini tamamlayan reflülü 32 renal üniteli hastada tek enjeksiyon sonrası total kür oranı %31.2'dir (32 renal üniteden 10'u). Bir kez tekrarlanan enjeksiyon sonrası bu oran %40.6'dır (32 renal üniteden 13'ü). 36 aylık takip sonunda toplam 19 üretere reimplantasyon yapılmıştır. Kollajen enjeksiyonun uzun dönem takipte etkisiz olduğunu düşünmekteyiz. Bu yönteminin uzun dönem için etkinliğini belirlemede daha fazla sayıda çalışmaya ihtiyaç vardır. Ayrıca uzun dönem takipte, daha çok VCUG'lar ve eğer reflü tespit edilirse tekrarlayan enjeksiyonlar için daha fazla anestezi gerekecektir.

The long term effectiveness of endoscopic subureteral collagen injection in the treatment of primary vesicoureteral reflux

We retrospectively evaluated the long-term effectiveness of the subureteral collagen injection in the treatment of vesicoureteral reflux (VUR). A total of 32 renal units were treated with subureteric collagen injection. Patients with grade 1, 4 and 5 reflux and severe lower urinary tract dysfunctions, were excluded from the study. After excluding the patients who still had reflux at 1-month follow-up after single injection, 32 renal units with complete 36-month follow-up were included into the study. At 6 months there was no reflux in 21 of 32 (65.6%) renal units. At 12 months follow-up, there was still no reflux in 18 (56.2%) and 22 (68.7%) renal units; at 24 months follow- up, 14 (43.7%) and 17 (53.1%) renal units showed no reflux after single injection and one re-injection, respectively. In patients with 32 refluxing renal units, who completed their 36 months follow-up, overall cure rate of after single injection were 31.2% (10 out of 32 renal units). This rate was 40.6% (13 out of 32 renal units) after 1 repeat injection. A total of 19 ureter had been re-implanted at the end of 36 months follow-up. We think that, collagen injection is ineffective in the longterm follow-up. Further studies are needed to determine the effectiveness of this method for long term. Furthermore, in the long term follow-up, more VCUG's and if reflux is found more anesthesia will be needed for repeat injections.

___

  • 1. Matouscheck E. Die Behandlung des vesikorenalen refluxes durch transurethrale Einsprit-zung von Teflon paste. Urologe 1981; 20: 263-4. 2. O’Donnell B, Puri P. Endoscopic correction of primary vesicoureteric reflux. Br J Urol 1986; 58: 601-4. 3. Haferkamp A, Contractor H, Mohring K ve ark. Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long term follow-up. Urol 2000; 55: 759-63. 4. Haferkamp A, Mohring K, Staehler G ve ark. Pitfalls of repeat subureteral bovine collagen injection for the endoscopic treatment of vesicoureteral reflux J Urol 2000;163: 1919-21. 5. Capozza N, Patricolo M, Lais A ve ark. Endoscopic treatment of vesico-ureteral reflux: Twelve years experience. Urol Int 2001; 67: 228-31. 6. Joyner B, Atala A. Endoscopic substances for the treatment of vesicoureteral reflux. Urol 1997; 50: 489-94. 7. Kershen RT, Atala A. New advances in injectable therapies for the treatment of vesicoureteral reflux. Urol Clin North Am 1999; 26: 81-94. 8. Haferkamp A, Mohring K, Staehler G ve ark. Long term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases. J Urol 2000;163: 274-7. 9. Frankenschmidt A, Katzenwadel A, Zimmerhackl LB. Endoscopic treatment of reflux by subureteric collagen injection. Critical review of 5 years’ experience. J Endourol 1997;11: 343-8. 10.Puri P, O’Donnel B. Correction of experimentally produced vesicoureteric reflux in the piglet by intravesical injection of Teflon. Brit Med J 1984; 289: 5-7. 11.O’Donnel B, Puri P. Treatment vesicoureteric reflux by endoscopic injection of Teflon. Brit Med J 1984; 289: 7-9. 12.Mittleman RE, Marraccini JV. Pulmonary Teflon granulomas following periurethral Teflon injection for urinary incontinence. Arch Path Lab Med 1983; 107: 611-2. 13.Malizia AA, Rieman HM, Myers RP ve ark. Migration and granulomatous reaction after periurethral injection of Polytef (Teflon) JAMA 1984; 251: 3277-81. 14.Malizia AA, Ruhston HG, Woodard JR ve ark. Migration and granulomatous reaction after intravesical/subureteric injection of Polytef. J Urol, part2 1987, 137: 122A, abstract 74. 15.Rames RA, Aaronson IA. The migration polytef paste to the lung and brain following intravesical injection for the correction of reflux. Ped Surg Int 1991; 6: 239-40. 16.Frey P, Curschellas E, Kaeslin M. Long term histological results following glutaraldehyde cross-linked collagen injection into the subureteral space of the mini-pig bladder. Ped Surg Int 1991; 6: 252-60. 17.Kempter F, Mohring K, Bersch W. Results of endoscopic subureteral collagen injection for reflux correction in pigs and dogs. Ped Surg Int 1991; 6: 261-8. 18.Reunanen MS, Toikkanen S, Viljanto J. Longterm follow-up of tissue reactions caused by Teflon paste and cross-linked collagen in rats. Ped Surg Int 1991; 6: 241-50. 19.Frey P, Gudinchet F, Jenny P. Gax65: a new injectable cross-linked collagen for the endoscopic treatment of vesicoureteral reflux- a double-blind study evaluating its efficiency in children. J Urol 1997;158: 1210-2. 20.Frey P, Berger D, Jenny P ve ark. Subureteral collagen injection for the endoscopic treatment of vesicoureteral reflux in children. Follow-up study of 97 treated ureters and histological analysis of collagen implants. J Urol 1992; 148: 718-23. 21.Frey P, Lutz N, Jenny P ve ark. Endoscopic subureteral collagen injection for the treatment of vesicoureteral reflux in infants and children. J Urol 1995; 154: 804-7. 22.Capozza N, Caino P, DeGennaro M ve ark. Endoscopic treatment of vesico-ureteric reflux and urinary incontinence: technical problems in the pediatric patients. Br J Urol 1995; 75: 538-42. 23.Reunanen M. Correction of vesicoureteral reflux in children by endoscopic collagen injection: a prospective study. J Urol 1995; 154: 2156-8. 24.Lipsky H. Long-term outcome of endoscopic treatment of vesicoureteral reflux. Urologe A 2000; 39: 246-50. 25.De Grazia E, Cimador M. Long-term follow-up results of vesico-ureteral reflux treated with subureteral collagen injection (SCIN). Minerva Pediatr 2000; 52: 7-14.